Introduction
Atherosclerosis is a chronic inflammatory disease characterized by leukocyte infiltration of the arterial vessel wall (Ross 1999 , Libby 2002 . Recruitment of leukocytes, such as monocytes, lymphocytes, and neutrophils, to the arterial vessel wall is the first step in the initiation of atherosclerosis (Ross 1999 , Libby 2002 . Leukocyte infiltration into the vessel wall is achieved through the welldefined dynamic adhesion cascade that includes the capture, rolling, slow rolling, firm adhesion, and transmigration of leukocytes. Capture (or tethering) is the first step of leukocyte adhesion, which functions to decelerate fast-flowing leukocytes from the central blood stream and enables them to interact closely (rolling) with the activated endothelium and to survey for immobilized chemokines on the surface of activated endothelium. Rolling leukocytes transduce signals from adhesion receptors and chemokine receptors, which activate downstream adhesion molecules that mediate slow rolling and firm adhesion to the endothelium. Adherent leukocytes then infiltrate the arterial vessel wall ). Each of these steps is mediated by the coordinated actions of different adhesion molecules. The interactions of selectins with their ligands mediate capture and most rolling events, whereas the interactions of members of the immunoglobulin family with leukocyte integrins mediate firm adhesion and migration ). Chemokines and chemokine receptors are also important in leukocyte adhesion and migration (Olson and Ley 2002 , Zernecke et al. 2008a , 2008b . In blood flow conditions, especially arterial flow conditions, the initial capture and rolling steps, which are mediated by selectins and their ligands, serve as an anchoring system to capture flowing leukocytes and initiate rolling on the endothelium for subsequent firm adhesion and transmigration. Recently, studies have demonstrated that selectins and their ligands also play a crucial role in the selective recruitment of certain types of leukocytes into atherosclerotic lesions ).
Selectin and Their Common Ligands
Selectins are a family of three calciumdependent lectins that consist of P-, E-, and L-selectins. P-selectin and E-selectin are expressed on activated endothelial cells and/or platelets, whereas L-selectin is expressed on leukocytes. Each selectin mediates adhesion in part through interactions of its N-terminal lectin domain with a sialyl Lewis x (sLe x ) capping structure (NeuAcα2-3Galβ1-3[Fucα1-3] GlcNAcβ1-R) that is found on selectin ligands. All selectin ligands are cell-surface glycoproteins. Among them, P-selectin glycoprotein ligand-1 (PSGL-1) is the only selectin ligand that has been extensively characterized at the molecular, cellular, and functional levels (McEver and Cummings 1997) . P-selectin glycoprotein ligand-1 is a transmembrane glycoprotein comprising extracellular, transmembrane, and cytoplasmic domains (McEver and Cummings 1997) . The extracellular polypeptide of PSGL-1 is rich in threonines and serines to which O-linked oligosaccharides (Oglycans) are frequently attached (McEver and Cummings 1997) . P-selectin glycoprotein ligand-1 interacts with all three selectins ( Figure 1A ). Its N-terminal region contains tyrosine sulfate residues and a core 2 O-glycan capped with sLe x that are essential for binding to selectins ( Figure 1B) . The O-linked branching enzyme core 2 β1,6-glucosaminyltransferase-I (C2GlcNAcT-I) and a β1,4 galactosyltransferase-I ( β1,4GalT-I) are essential for the formation of the branched core 2 O-glycan, whereas two α1,3-fucosyltransferases, FucT-VII and FucT-IV, and at least two sialyltransferases of the ST3Gal family, one of which is ST3Gal-IV, are required to form the sLe x . Antibody-blocking studies and genetic deletion of PSGL-1 indicate that PSGL-1 is the only physiologically relevant ligand for P-and L-selectin on leukocytes. Modification by FucT-VII, C2GlcNAcT-I, β1,4GalT-I, and at least one ST3Gal is essential for PSGL1 binding to P-and L-selectins. P-selectin glycoprotein ligand-1 is also able to bind to E-selectin, and this activity of PSGL1 requires modifications by FucT-VII and ST3Gal (McEver and Cummings 1997, Ley and Kansas 2004) .
P-selectin glycoprotein ligand-1 is constitutively expressed on all leukocytes. However, its expression level and degree of glycosylation differ significantly in different subtypes of leukocytes. The differential expression and glycosylation has been found to contribute to selective recruitment of different types of leukocytes to atherosclerotic lesions , Wang et al. 2009 Macrophages are the predominant cellular components in early atherosclerotic lesions (Ross 1999 , Libby 2002 . Lesion macrophages are differentiated from circulating blood monocytes, and macrophages in lesions behave differently. For example, macrophages adjacent to the cholesterol clefts and within the necrotic cores express high levels of tissue factor, whereas macrophages in the shoulders of lesions produce the enzymes myeloperoxidase and neutrophil elastase. In addition, macrophages within the advanced human atheroma appear to express high levels of apolipoprotein E (apoE) . The diverse activities of macrophages in atherosclerotic lesions suggest a lineal difference for macrophages in atherosclerotic lesions, which may result from the heterogeneity of circulating blood monocytes.
Blood monocytes are heterogeneous (Sunderkotter et al. 2004 (Geissmann et al. 2003) . Heterogeneous monocytes may not be differentiated from different lineages of myeloid precursors. A few studies have shown that Ly-6C hi monocytes are cells that are newly released from bone marrow. These cells mature in circulating blood and are gradually converted to Ly-6C lo monocytes (Tacke et al. 2007 ). In wild-type mice, the numbers of Ly-6C hi and Ly-6C lo monocytes are well balanced, with a ratio of one to one. Interestingly, inflammatory stimuli, such as hypercholesterolemia, impair the conversion of Ly-6C hi to Ly-6C lo , thus, increasing the number of circulating Ly-6C hi monocytes in mice (Tacke et al. 2007 , Swirski et al. 2007 ).
It appears that there is a distinct difference in the profile of adhesion molecules and chemokine receptors on resident and inflammatory monocytes (Table 1) hi monocytes are preferentially recruited to atherosclerotic plaques and give rise to lipid-laden macrophages in apoE-deficient (ApoE −/− ) mice (Swirski et al. 2007 ). Ly-6C hi monocytes are recognized as the key monocyte subset in the development of atherosclerosis, but the mechanism by which these monocytes selectively accumulate in atherosclerotic lesions is largely unknown. CCR2 is differentially expressed on Ly-6C hi cells and is important for monocytes to enter atherosclerotic lesions, but it does not mediate the early adhesion steps, such as tethering and initial rolling, which are the prerequisite for selective homing of leukocytes (Huo et al. 2001 ). P-selectin glycoprotein ligand-1 expressed on monocytes is fully modified by glycosyltransferases and able to interact with selectins. However, recently, we have found that Ly-6C hi monocytes express a higher level of PSGL-1 and have enhanced binding to the P-, E-, and L-selectins compared with Ly-6C lo monocytes . We demonstrate that PSGL-1 plays a key role in mediating the selective homing of Ly-6C hi to arterial walls in atherosclerosis ( Figure 2A) . First, PSGL-1 mediates Ly-6C hi monocyte homing via primary tethering. P-selectin glycoprotein ligand-1 on Ly-6C hi monocytes interact with P-selectin either on activated endothelial cells, on neointimal smooth muscle cells (Zeiffer et al. 2004 ), or on activated platelets adhered to the injured arterial wall ( Figure 2A ). P-selectin glycoprotein ligand-1 may also mediate tethering and rolling on E-selectin on the activated endothelium, either independently or in cooperation with other leukocyte E-selectin ligand(s) (Xia et al. 2002) . Second, secondary tethering may serve as another important mechanism for selective Ly-6C hi monocyte homing ( Figure  2A ). Secondary tethering occurs when a freely flowing leukocyte transiently interacts with a rolling or adherent leukocyte or adherent leukocyte fragments and subsequently rolls on the endothelium ). L-selectin on Ly-6C hi monocytes interacts with PSGL-1 on another leukocyte to mediate Ly-6C hi monocyte secondary tethering. Neutrophils have a high level of PSGL-1 and are able to interact with atherosclerotic arteries (Eriksson et al. 2001 ). Owing to a much higher number of neutrophils than monocytes in circulation, in vivo, there will be a high frequency of secondary tethering of a flowing Ly-6C hi monocyte on neutrophils rolling on or adherent to atherosclerotic arteries. Thus, PSGL-1, through a primary and a possible secondary capturing mechanism, selectively homes Ly-6C hi monocytes to atherosclerotic sites. In contrast, Ly-6C lo monocytes express a low level of PSGL-1 and are impaired in these homing mechanisms ( Figure 2B ). In addition to its capturing function, PSGL-1 can induce leukocyte activation, including calcium influx, activation of integrins, and slow rolling (Wang et al. 2007 , Zarbock et al. 2007 ). These effects may also contribute to PSGL-1-mediated selective recruitment of inflammatory monocytes to atherosclerotic arterial wall.
Atherosclerotic lesions are prone to develop at bifurcations, branching, and curvatures where the shear stress ranges from 1 to 3 dyn/cm 2 (Pantos et al. 2007 ). Neointimal lesions after wire injury develop at locations where shear stress can be much higher because of the angioplasty procedure. Thus, the high level of functional PSGL-1 may give Ly-6C hi monocytes a unique homing advantage under arterial flow conditions. Indeed, the lack of PSGL-1 protected ApoE −/− mice from developing severe wire injuryinduced neointimal and atherosclerotic plaques, which may be attributable to diminished Ly-6C hi monocyte recruitment. Significantly, the lack of PSGL-1 provides ApoE −/− mice more protection from developing neointimas than atherosclerotic plaques, which supports the contention that PSGL-1 plays a more important role in the recruitment of monocytes in acute lesions than in chronic lesions ).
Regulated Glycosylation of PSGL-1 Plays a Key Role in Mediating Activated Lymphocyte Selective Homing to Atherosclerotic Vessels
In humans, T cells have long been found in atherosclerotic plaques (Jonasson et al. 1985) . In mice lacking apoE or the low-density lipoprotein receptor, T cells, especially CD4 T cells, are the predominant lymphocytes in atherosclerotic lesions (Roselaar et al. 1996) . The presence of T cells in atherosclerotic lesions has a causative role in the formation of atherosclerotic lesions in mice. In lossof-function experiments, mice with a global deficiency of adaptive immunity have decreased atherosclerosis. In contrast, the adoptive transfer of CD4 T cells to those immune-deficient mice accelerates the formation of atherosclerotic lesions (Zhou et al. 2000 , Song et al. 2001 , demonstrating that CD4 T cells play a pathogenic role in atherosclerosis. Most T cells found in lesions are effector or memory T cells, and the proportion of the activated T cells increases with the severity of atherosclerosis (Hansson et al. 1989) . Naive T cells are rarely found in atherosclerotic plaques. All T cells express a similar level of PSGL-1; yet, naïve T cells do not interact with P-and E-selectins on activated endothelium because their PSGL-1 is not appropriately glycosylated and is, thus, not functional (Ley and Kansas 2004) . However, naïve T cells can home to regional lymph nodes through PSGL-1-independent mechanism (L-selectin interacting with peripheral node addressins [PNAd] on the high endothelium of lymph nodes). In regional lymph nodes, naïve T cells interact with activated dendritic cells, which emigrated from atherosclerotic lesions (Robertson and Hansson 2006) . The interactions of naïve T cells with dendritic cells and local proinflammatory cytokines regulate glycosyltransferases that are related to selectin ligand activity. For example, the expression of FucT-VII is upregulated through the T-cell receptor, possibly through Ras, and by the ligation of interleukin-12 (IL-12R) (Barry et al. 2003) . C2GlcNAcT-I expression is upregulated by IL-12 through a signal transducer and activator of transcription (STAT4) and by IL-2 and IL-4, possibly through STAT5 and STAT6 (Lim et al. 1999) , respectively. Increased levels of FucT-VII and C2GlcNAcT-I transform PSGL1 to its functional form that binds to all three selectins. Therefore, regulated glycosylation of PSGL-1 is essential for PSGL-1 to mediate the selective recruitment of activated T cells to atherosclerotic lesions ( Figure 3A) . Activated CD4 memory T cells of the T helper 1 and 2 (T H 1, T H 2)-cell types are found in atherosclerotic lesions (Roselaar et al. 1996) . During early lesion formation, T H 1 cells predominate over the T H 2-cell subset, secrete interferon-γ cytokine, and propagate adaptive immune reactivity through the induction of MHC (major histocompatability complex) class II on antigen-presenting cells and the stimulation of smooth muscle cell proliferation in vivo (Robertson and Hansson 2006) . Deficiency of T-bet, a T H 1-cell-associated transcription factor, leads to attenuated atherosclerosis, further demonstrating the proatherogenic effect of T H 1 (Buono et al. 2005) . With the progression of atherosclerosis, T H cells in plaque diametrically balance, shifting from a T H 1-cell type to a T H 2-cell type. The latter produces cytokines, such as IL-4 and IL-10, and increases antibodies against oxLDL (oxidized lowdensity lipoprotein), which consequently 
suppresses atherosclerosis (Robertson and Hansson 2006) . Fully glycosylated PSGL-1 on T H 1 or T H 2 cells interacts with the Pand E-selectins on atherosclerotic endothelium or on platelets or platelet microparticles adhering to the endothelium and mediates the selective recruitment of these cells to atherosclerotic lesions (Ley and Kansas 2004) . In addition, neutrophils, monocytes, and their particles adhering to atherosclerotic endothelium present their PSGL-1 to T cells. Thus, PSGL-1 can interact with L-selectin on T cells to mediate T cell homing to atherosclerotic arteries (Ley and Kansas 2004) (Figure 3) . ApoE −/− mice lacking C2GlcNAcT-I have a defect in PSGL-1 function. As a result, the number of T cells infiltrated in atherosclerotic lesions is dramatically decreased ).
PSGL-1 in Homing of Other Leukocytes to Atherosclerotic Arteries
Neutrophils and mast cells have been found in atherosclerotic lesions, and these cells contribute to the formation of atherosclerotic lesions (Weber et al. 2008) . In atherosclerotic mice, immunostaining with antibodies specific to neutrophils has shown the presence of neutrophils in the luminal-plaque regions and also in the adventitia. Longterm disruption of the interactions between CXCR4 and its ligand CXCL12 (SDF1α) results in the homeostatic expansion of neutrophils in the circulation. This leads to an increase of neutrophil infiltration in atherosclerotic lesions and the aggravation of atherosclerosis. A neutrophil-neutralizing antibody reduced the circulating neutrophil number and consequently suppressed the exacerbation of atherosclerosis induced by CXCR4 deficiency (Zernecke et al. 2008a (Zernecke et al. , 2008b . Thus, a role for neutrophils in the formation of atherosclerotic lesions is indicated. In ApoE −/− mice that are treated with cytokine tumor necrosis factor α or IL-β, neutrophils interact with the endothelium of large arteries or atherosclerotic arteries under intravital microscopy. The major types of interactions are capture and rolling, which are dependent on P-and E-selectins. Because PSGL-1 is the major ligand for the P-and E-selectins, PSGL-1 is presumed to be critically involved in neutrophil interactions with atherosclerotic arteries. Mast cells in atherosclerotic lesions release tumor necrosis factor α and IL-6 and consequently contribute to the formation of atherosclerotic lesion and elastase-induced aortic aneurysms. In mast-cell-deficient mice, atherosclerosis is significantly suppressed (Sun et al. 2007 ). The molecular mechanism for mast cell homing to atherosclerotic arteries in vivo remains to be investigated. However, under in vitro flow conditions, cultured mast cells interact with the selectin-coated surfaces or activated endothelial monolayers through a PSGL-1-dependent mechanism (Steegmaier et al. 1997) , indicating that mast cells may also use PSGL-1 to home to atherosclerotic arteries.
P-selectin glycoprotein ligand-1 as a Therapeutic Target for Atherosclerosis and Arterial Injury
It has been demonstrated that a single injection of anti-PSGL-1-blocking antibody is able to dramatically inhibit the growth of arterial neointima after wireinduced arterial injury in ApoE −/− mice (Phillips et al. 2003 ). An even greater protection from arterial neointima formation after arterial injury is seen in ApoE/PSGL-1 double-deficient mice in our recent experiment ). In addition, inhibiting the glycosylation of PSGL-1 by deleting FucT or C2GlcNAcT-I also ameliorates atherosclerosis and arterial neointima formation after arterial injury. FucT-IV deficiency results in a modest decrease in monocyte P-selectin ligand activity and is associated with a subtle decrement in atherosclerosis. FucT-VII deficiency substantially decreases the interactions of monocytes with selectin-coated surfaces under flow conditions and the size of atherosclerotic lesions in ApoE −/− mice (Homeister et al. 2004 ). C2GlcNAcT-I deficiency almost completely abrogates leukocyte binding to P-and E-selectin and decreases Ly-6C hi monocyte interactions with atherosclerotic arteries under physiologic flow conditions. In ApoE −/− mice, the lack of C2GlcNAcT-I results in fewer and smaller atherosclerotic lesions in mouse aortas and a smaller arterial neointima after arterial injury compared with lesions and arterial neointima in control mice (Wang et al. , 2009 ). P-selectin glycoprotein ligand-1 is also highly expressed on human CD14 + CD16 − monocytes . The glycosylation pathways are identical in humans and mice. In addition to its capturing and signaling functions, PSGL-1 also mediates chemokine presentation and further affect leukocyte recruitment (Veerman et al. 2007 ). Thus, PSGL-1 blockade and/or therapeutic interventions of glycosylation pathways represent potential therapeutic approaches for the treatment of atherosclerosis or restenosis after angioplasty.
Conclusion
Leukocyte recruitment to the arterial vessel wall initiates and mediates the progression of atherosclerosis. Recent studies have identified the involvement of different leukocyte subsets in the pathology of this disease. The selectin ligand PSGL-1 initiates leukocyteendothelial interactions for all leukocytes. In vivo studies reveal that PSGL-1 plays a crucial role in the recruitment of proatherogenic leukocyte subsets to the arterial wall in mice, which is prerequisite in the formation and progression of atherosclerotic lesions. Thus, the inhibition of PSGL-1 function is a potential therapeutic approach to the treatment of atherosclerosis and arterial restenosis.
